Literature DB >> 17873167

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).

Gene L Colice1, Shirin Shafazand, John P Griffin, Robert Keenan, Chris T Bolliger.   

Abstract

BACKGROUND: This section of the guidelines is intended to provide an evidence-based approach to the preoperative physiologic assessment of a patient being considered for surgical resection of lung cancer.
METHODS: Current guidelines and medical literature applicable to this issue were identified by computerized search and evaluated using standardized methods. Recommendations were framed using the approach described by the Health and Science Policy Committee.
RESULTS: The preoperative physiologic assessment should begin with a cardiovascular evaluation and spirometry to measure the FEV(1). If diffuse parenchymal lung disease is evident on radiographic studies or if there is dyspnea on exertion that is clinically out of proportion to the FEV(1), the diffusing capacity of the lung for carbon monoxide (Dlco) should also be measured. In patients with either an FEV(1) or Dlco < 80% predicted, the likely postoperative pulmonary reserve should be estimated by either the perfusion scan method for pneumonectomy or the anatomic method, based on counting the number of segments to be removed, for lobectomy. An estimated postoperative FEV(1) or Dlco < 40% predicted indicates an increased risk for perioperative complications, including death, from a standard lung cancer resection (lobectomy or greater removal of lung tissue). Cardiopulmonary exercise testing (CPET) to measure maximal oxygen consumption (Vo(2)max) should be performed to further define the perioperative risk of surgery; a Vo(2)max of < 15 mL/kg/min indicates an increased risk of perioperative complications. Alternative types of exercise testing, such as stair climbing, the shuttle walk, and the 6-min walk, should be considered if CPET is not available. Although often not performed in a standardized manner, patients who cannot climb one flight of stairs are expected to have a Vo(2)max of < 10 mL/kg/min. Data on the shuttle walk and 6-min walk are limited, but patients who cannot complete 25 shuttles on two occasions will likely have a Vo(2)max of < 10 mL/kg/min. Desaturation during an exercise test has not clearly been associated with an increased risk for perioperative complications. Lung volume reduction surgery (LVRS) improves survival in selected patients with severe emphysema. Accumulating experience suggests that patients with extremely poor lung function who are deemed inoperable by conventional criteria might tolerate combined LVRS and curative-intent resection of lung cancer with an acceptable mortality rate and good postoperative outcomes. Combining LVRS and lung cancer resection should be considered in patients with a cancer in an area of upper lobe emphysema, an FEV(1) of > 20% predicted, and a Dlco of > 20% predicted.
CONCLUSIONS: A careful preoperative physiologic assessment will be useful to identify those patients who are at increased risk with standard lung cancer resection and to enable an informed decision by the patient about the appropriate therapeutic approach to treating their lung cancer. This preoperative risk assessment must be placed in the context that surgery for early-stage lung cancer is the most effective currently available treatment for this disease.

Entities:  

Mesh:

Year:  2007        PMID: 17873167     DOI: 10.1378/chest.07-1359

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  85 in total

1.  [Preoperative evaluation and risk estimation in thoracic surgery].

Authors:  H Mutlak; S Czerner; H Winter; B Zwissler; P Lackermeier
Journal:  Anaesthesist       Date:  2010-10       Impact factor: 1.041

Review 2.  Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis.

Authors:  Lee W Jones; Yuanyuan Liang; Edith N Pituskin; Claudio L Battaglini; Jessica M Scott; Whitney E Hornsby; Mark Haykowsky
Journal:  Oncologist       Date:  2011-01-06

Review 3.  Exercise therapy in the management of solid tumors.

Authors:  Lee W Jones; Jeffrey Peppercom; Jessica M Scott; Claudio Battaglini
Journal:  Curr Treat Options Oncol       Date:  2010-06

4.  Outcomes of lung cancer resection for patients with combined pulmonary fibrosis and emphysema.

Authors:  Mariko Fukui; Kenji Suzuki; Takeshi Matsunaga; Shiaki Oh; Kazuya Takamochi
Journal:  Surg Today       Date:  2015-08-15       Impact factor: 2.549

Review 5.  Lung Cancer OncoGuia.

Authors:  Paula Manchon Walsh; Paula Manchon; Josep M Borràs; Tàrsila Ferro; Josep Alfons Espinàs
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

Review 6.  Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.

Authors:  Namrata Patel; Malcolm DeCamp; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Desaturation during the stair-climbing test for patients who will undergo pulmonary resection: an indicator of postoperative complications.

Authors:  Takahito Nakamura; Noriyoshi Sawabata; Yoshiyuki Susaki; Shigeo Muro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-06-04

8.  Clinical relevance of decreased oxygen saturation during 6-min walk test in preoperative physiologic assessment for lung cancer surgery.

Authors:  Tatsuo Nakagawa; Naohisa Chiba; Masao Saito; Yasuto Sakaguchi; Shinya Ishikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-09

9.  Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease.

Authors:  Fei Cui; Jun Liu; Wenlong Shao; Jianxing He
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

10.  Influence of Pulmonary Rehabilitation on Lung Function Changes After the Lung Resection for Primary Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Natasa Mujovic; Nebojsa Mujovic; Dragan Subotic; Maja Ercegovac; Andjela Milovanovic; Ljubica Nikcevic; Vladimir Zugic; Dejan Nikolic
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.